Simcere Pharmaceutical Co., Ltd

This study tested a new medication called SIM0718 in 259 adults and teenagers (ages 12-75) with moderate to severe atopic dermatitis (eczema). The goal was to see if it improves skin symptoms like redness and itching compared to a placebo. Participants received either the drug or…

This study looked at how a single dose of SIM0718 injection is processed by the body in 178 healthy adults aged 18-50 in China. The main goal was to measure drug levels and check for side effects. It is an early-phase trial to gather basic safety and drug behavior information.